Tag
Tag: Innate Pharma
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer
Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold
Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
French Biotech Announces Positive Phase I Results in T-cell Lymphoma
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
How is Biotech Transforming Pharma’s R&D Model?
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
